 |
Return Create A Forum - Home |
 |
--------------------------------------------------------- |
|
MS Speaks |
 |
https://msspeaks.createaforum.com |
|
--------------------------------------------------------- |
|
***************************************************** |
|
Return to: OCREVUS (ocrelizumab) |
|
***************************************************** |
|
#Post#: 4594-------------------------------------------------- |
|
(Nature) Ocrelizumab biosimilar Xacrel compared to Ocrevus... |
|
By: agate Date: October 23, 2024, 1:11 am |
|
--------------------------------------------------------- |
|
From Nature (October 22, 2024)--"Evaluating efficacy and safety |
|
of ocrelizumab (Xacrel) compared to the originator (Ocrevus) in |
|
relapsing multiple sclerosis: A phase 3, randomized, |
|
equivalency, clinical trial": |
|
https://www.nature.com/articles/s41598-024-75745-y |
|
***************************************************** |
